Skip to content

Brain Activation Patterns in Schizophrenia After Computerized Cognitive Skills Training

Does Computerized Cognitive Skills Training Change Brain Activation Patterns in Schizophrenia?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00431223
Acronym
fMRI
Enrollment
11
Registered
2007-02-05
Start date
2006-09-30
Completion date
2008-09-30
Last updated
2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Keywords

fMRI, working memory, schizophrenia, treatment refractory, cognitive skills training, dorsolateral prefrontal cortex, cognitive remediation, treatment refractory schizophrenia of > 5 years duration

Brief summary

This project is a novel exploratory research project to investigate changes in activation patterns of the dorsolateral prefrontal cortex (DLPFC) in inpatients with schizophrenia who received a 12-week computerized cognitive remediation (CRT) program. The hypothesis is that patients receiving CRT will show greater increase in activation patterns in the brain as compared to controls, and the degree of brain activation will correlate with improvements in working memory.

Detailed description

Abnormalities in the domains of attention, working memory (WM) and information processing are important features of schizophrenia. There is growing literature that cognitive remediation therapy (CRT) can produce modest improvements in cognitive functioning in schizophrenia, suggesting that systematic efforts at improving cognitive functioning are feasible. Cognitive improvement after CRT may correlate with changes in brain activation patterns in specific areas. After screening, patients are randomized to a 12 week trial of CRT using COGPACK (Marker Software), or to a 12-week control condition. All patients attend 3 weekly 1-hour laboratory sessions, with 1 discussion session per week. Patients continue their antipsychotic treatment with a typical or atypical antipsychotic during the CRT and 4 weeks prior to enrollment in the study (Phase A). Following Phase A they receive baseline evaluations, including an cognitive activation task (N-back visual-letter task) while being scanned for fMRI , MATRICS neuropsychological test battery, and psychiatric, social functioning, and symptoms assessment. Patients then enter Phase B with randomization to control or CRT for 12 weeks (36 laboratory sessions). Upon successful completion of 36 sessions, endpoint evaluations include an N-back task while fMRI scan, MATRICS, psychiatric, and social functional assessments. All baseline and endpoint fMRI scans are conducted at the Center for Advanced Brain Imaging (CABI) at Nathan Kline Institute for Psychiatric Research.

Interventions

BEHAVIORALCognitive remediation therapy

36 sessions of computerized cognitive skills training over a 12 week duration. 7 patients were assigned to cognitive remediation therapy or CRT Group.

Sponsors

Nathan Kline Institute for Psychiatric Research
CollaboratorOTHER
Manhattan Psychiatric Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Inpatient status * Age 18 - 55 * Male gender (females are enrolled but will not be scanned) * DSM-IV diagnosis of schizophrenia (all subtypes) and schizoaffective disorder * illness duration \> 5 years * MMSE score \> 24 (inclusive) at screening * Stable dose of oral atypical antipsychotic for at least 4 weeks prior to study entry * Total PANSS score \> 60 at screening * Capacity and willingness to give written informed consent * Patients deemed not ready to be discharged within the next 12 weeks

Exclusion criteria

* Inability to read or speak English * Documented disease of the central nervous system * History of intellectual impairment pre-dating onset of symptoms of psychosis (e.g. mental retardation) * Clinically significant or unstable cardiovascular, renal, hepatic, gastrointestinal, pulmonary, or hematological conditions; HIV positive * Any medical condition rendering the subject unable to receive an fMRI scan

Design outcomes

Primary

MeasureTime frame
Brain activation changes after stimulation with a neurocognitive task in the dorso-lateral prefrontal cortex (DLPFC)12 weeks

Secondary

MeasureTime frame
Examine the relationship of changes in DLPFC activation patterns in relation to improvement on neurocognitive tests12 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026